Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
Sofía Ramiro, Rémy L.M. Mostard, César Magro‐Checa, Christel M. P. van Dongen, Tom Dormans, Jacqueline Buijs, Michiel H. M. Gronenschild, Martijn D. de Kruif, E.H.J. van Haren, Tom van Kraaij, Mathie P.G. Leers, Ralph Peeters, Dennis R. Wong, Robert Landewé
Topics & Concepts
TocilizumabMedicinePneumoniaCytokine stormMechanical ventilationMethylprednisoloneCytokine release syndromeInternal medicineGastroenterologyCoronavirus disease 2019 (COVID-19)Rheumatoid arthritisDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Adrenal Hormones and Disorders